Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study

Bibliographic Details
Title: Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study
Authors: Calles, Antonio a, ∗, Navarro, Alejandro b, c, Doger de Speville Uribe, Bernard Gaston d, Colomé, Enric Álvarez b, de Miguel, María e, Álvarez, Rosa a, Arregui, Marta a, Moreno, Víctor d, Rocha, Pedro b, Calvo, Emiliano e, Ramon-Patino, Jorge e, Corral de la Fuente, Elena e, Alcalá-López, Daniel c, Boix, Olga c, Fernández-Pinto, Melissa c, Rodríguez-Morató, Jose c, Palmero, Ramón f, Nadal, Ernest f, Jove, Maria f, Felip, Enriqueta b
Source: In Journal of Thoracic Oncology February 2025
Database: ScienceDirect
More Details
ISSN:15560864
DOI:10.1016/j.jtho.2025.02.005
Published in:Journal of Thoracic Oncology
Language:English